EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY 4.0

Therapeutic Response to Neoadjuvant Chemotherapy and Associated Factors in Breast Cancer Patients: A Cameroon Cohort Study

Berthe Sabine Esson Mapoko, Etienne Atenguena Okobalemba, Kenn Chi Ndi, Kareen Azemafac, Zainab Innapetel Abba, Lionel Armel Bala, Cyril Wilfried Admire Missinga, Lionel Tabola Fossa, Paul Ndom

Advances in Breast Cancer Research · 2026 · 15 (02) · 66-83

DOI: 10.4236/abcr.2026.152006 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Advances in Breast Cancer Research, 2026. Verfasst von Berthe Sabine Esson Mapoko und 8 weiteren Autor:innen. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Mapoko, B. S. E., Okobalemba, E. A., Ndi, K. C., Azemafac, K., Abba, Z. I., Bala, L. A., Missinga, C. W. A., Fossa, L. T., & Ndom, P. (2026). Therapeutic Response to Neoadjuvant Chemotherapy and Associated Factors in Breast Cancer Patients: A Cameroon Cohort Study. Advances in Breast Cancer Research, 15(02), 66-83. https://doi.org/10.4236/abcr.2026.152006

Vancouver

Mapoko BSE, Okobalemba EA, Ndi KC, Azemafac K, Abba ZI, Bala LA, et al. Therapeutic Response to Neoadjuvant Chemotherapy and Associated Factors in Breast Cancer Patients: A Cameroon Cohort Study. Advances in Breast Cancer Research. 2026;15(02):66-83. doi:10.4236/abcr.2026.152006

BibTeX
@article{Mapoko2026,
  author = {Mapoko, Berthe Sabine Esson and Okobalemba, Etienne Atenguena and Ndi, Kenn Chi and Azemafac, Kareen and Abba, Zainab Innapetel and Bala, Lionel Armel and Missinga, Cyril Wilfried Admire and Fossa, Lionel Tabola and Ndom, Paul},
  title = {Therapeutic Response to Neoadjuvant Chemotherapy and Associated Factors in Breast Cancer Patients: A Cameroon Cohort Study},
  journal = {Advances in Breast Cancer Research},
  year = {2026},
  volume = {15},
  number = {02},
  pages = {66--83},
  doi = {10.4236/abcr.2026.152006}
}
Kostenlos starten →